Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.3.0.814
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Income Statement [Abstract]        
Collaboration revenue $ 170,454 $ 0 $ 284,090 $ 0
Operating expenses:        
Research and development 1,634,800 452,600 4,065,486 683,960
General and administrative 790,576 365,603 2,571,521 704,185
Total operating expenses 2,425,376 818,203 6,637,007 1,388,145
Operating loss (2,254,922) (818,203) (6,352,917) (1,388,145)
Other income (expense):        
Interest expense 0 (650) (1,372) (23,045)
Interest income 1,037 802 2,145 1,425
Forgiveness of interest on note payable 0 7,466 0 7,466
Gain on the settlement of debt 0 145,006 0 145,006
Change in fair value of warrant liability 0 0 0 (28,448)
Foreign currency exchange loss 0 5,958 0 5,533
Other income, net 1,037 158,582 773 107,937
Net loss $ (2,253,885) $ (659,621) $ (6,352,144) $ (1,280,208)
Net loss per share, basic and diluted $ (0.06) $ (0.03) $ (0.22) $ (0.07)
Weighted average number of common shares outstanding, basic and diluted 34,770,597 25,542,755 29,242,236 18,242,956